With investment into the Treg field at an all time high, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of autoimmunity, inflammation and transplantation. As this enthusiasm coincides with multiple clinical readouts and several more therapies entering the clinic, it remains vital for Treg trailblazers to come together to recognize therapy efficacy, determine […]

The 2nd Cell Therapy Potency Assay will gather 100+ experts working to rationally design better potency assays to smooth the path to regulatory approval and minimize hold times with scientifically rigorous and informative potency measurements. Whether you are submitting your first IND or gearing up towards BLA submission, this critical meeting of minds is your premier opportunity to join the likes […]

Whether it’s in cardiovascular disease, Alzheimer’s or osteoarthritis, therapeutic innovations to target the mechanisms of aging are making significant headway to clinical trials. With increased investments and recognition, along with the escalation of the burden of age-related disease, research and development to meet this unmet medical need has never been more important. The 5th Age-Related Disease Therapeutics Summit is […]

With approvals in siRNA technology, more ASOs hurtling towards human trials in neurology, and exciting headlines in Alzheimer’s and ALS, the draw of CNS targets for oligonucleotides has never been greater. Massive investments and growing pipelines in pharma and biotech alike are working to make these life-changing therapies a reality for previously undruggable targets. Join […]

Returning as the pinnacle event in the industry, the 4th Annual Gene Therapy for Neurological Disorders Summit Europe (6-8 June 2023, Amsterdam) enables you to bring your gene therapy to patients in Europe. This year’s content takes a greater focus on: Innovation in preclinical models and vector technology Showcasing novel approaches to improve delivery in […]

Assessing Device Development and Regulation for Advanced Innovation Sponsors: Datwyler, Haselmeier, Mitsubishi Gas Chemical, Nemera, ZEON Exhibitors: Credence MedSystems, Kymanox, Noble, Owen Mumford Pharmaceutical Services, SCHERDEL Medtec SAE Media Group’s 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers, innovative biotech, and big […]

Advance your end-to-end logistics strategy to deliver vital therapeutics at the RIGHT TIME, RIGHT PLACE and the RIGHT TEMPERATURE Join us in Frankfurt in June 2023 in a brand-new venue at the heart of Europe, as once again, we return live and in-person for 3 days of interactive sessions, collaborative roundtables as well as formal and informal networking to maximise the […]

As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy is evolving. At this interface lies the 3rd Gene Therapy Patient Engagement Summit, uniting patient advocacy and engagement experts from leading gene therapy and gene […]

Returning for the 3rd year, the ILD Summit will lean into the industry’s key challenges, explore pipeline opportunity development, and look towards the future for ILD therapeutic development from idiopathic pulmonary fibrosis pipelines. From illuminating predictors of progression to define and identify the progressive fibrosis phenotypes for patient stratification to evolving clinical trial design with novel secondary and exploratory endpoints beyond FVC. This is a fantastic point in […]

With exciting developments in pioneering inhaled drug products from Moderna, Vertex, ReCode Therapeutics, and Pieris Pharmaceuticals, now is the time to go full speed ahead on your efforts into inhaled formulation and delivery optimization. Despite the inhalation drug delivery market being expected to reach $18.6 billion by 2029, achieving cell-specific delivery, and optimized stability remain vital challenges. This […]

Exciting results are expected this year, from multiple mid and late stage clinical trials and involving a broad array of adenosine drugs including CD73, CD39 and A2AR! To ensure the community can capitalize on this, the 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit will be returning this June (20 – 22) in Boston, MA – dedicated to […]

This event will take place in London on 21-22 June 2023 in London, focusing on the three biggest priorities enabling growth in the AMR field - Innovation, Investment & Policy - AMR Connect enables you to foster connections with key stakeholders in anti-microbial research and build actionable next steps to combat the silent pandemic. AMR […]

As the biggest industry-led meeting on novel vector development, the 3rd Annual Next Generation Gene Therapy Vectors Summit (June 27-29, 2023 | Boston, MA) will bring together 100+ key opinion leaders to help solve the safety, efficiency, and scalability challenges of the next generation of vectors. Industry heavyweights such as Novartis, Spark Therapeutics, Capsida Biotherapeutics, […]

The 8th Microbiome Movement Drug Development Summit returns in 2023 as North America's definitive microbiome drug development event - and it's back bigger and better than ever! The microbiome-based therapeutic market is rapidly evolving, and it's more important than ever to showcase the efficacy of microbial-based approaches beyond C. difficile. Discover how drug developers are […]